High-Cost Specialty Drug Utilization Review

MRIoA’s High-Cost Specialty Drug Review allows health plans, TPAs and PBMs to leverage MRIoA’s specialist MDs to ensure use of evidence-based guidelines for high-cost drugs in treating medical conditions where lower-cost drug alternatives are available. 

Streamline Your High-Cost Specialty Drug Reviews

• Reduce drug spend by identifying and recommending clinically appropriate and cost-effective therapeutic alternatives for patients on high-cost drugs
• Conduct a collaborative peer-to-peer call with prescriber to discuss therapeutic interchange alternatives

 ​​​​​